J Korean Med Sci.  2004 Dec;19(6):848-852. 10.3346/jkms.2004.19.6.848.

Clinical Outcomes of Patients treated for Cervical Pregnancy with or without Methotrexate

Affiliations
  • 1Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University, School of Medicine, Seoul, Korea. edoc24@smc.or.kr

Abstract

The objective of this study is to describe the clinical outcomes of patients treated for cervical pregnancy with or without methotrexate (MTX) and to evaluate the effects of MTX in the treatment of cervical pregnancy. Between January 1993 and February 2000, 31 patients were diagnosed with cervical pregnancy. Twenty-two patients were treated with MTX chemotherapy and nine patients were treated with surgical procedures without MTX treatment. In the non-MTX treatment group, three patients underwent total abdominal hysterectomy, five required adjuvant procedures to control the bleeding during dilatation and curettage (D&C) and only one patient was treated with a simple D&C. In the MTX treatment group, fourteen (63.6%) patients were treated with only MTX and eight (36.4%) cases underwent concomitant procedures (simple curettage, curettage and Foley catheter tamponade, cer-vical cerclage, ligation of the descending branches of uterine arteries, or ligation of hypogastric arteries). The uterus was preserved in all cases and three women delivered healthy babies in their subsequent pregnancy. In conclusion, early diagnosis, appropriate MTX regimen in combination of necessary adjuvant conservative procedures could contribute to successful treatment with preservation of the uterus and future reproductive ability.

Keyword

Methotrexate; Pregnancy, Ectopic; Cervix Uteri; Dilatation and Curettage; Drug Therapy

MeSH Terms

Abortifacient Agents, Nonsteroidal/administration & dosage
Comparative Study
Dilatation and Curettage/*statistics & numerical data
Female
Humans
Incidence
Korea/epidemiology
Methotrexate/*administration & dosage
Pregnancy
Pregnancy, Ectopic/*drug therapy/epidemiology/*surgery
Retrospective Studies
Risk Assessment/*methods
Risk Factors
Treatment Outcome

Reference

1. Parente JT, Ou CS, Levy J, Legatt E. Cervical pregnancy analysis: A review and report of five cases. Obstet Gynecol. 1983. 62:79–82.
2. Dees HC. Cervical pregnancy associated with uterine leiomyomas. South Med J. 1966. 59:900–905.
Article
3. Frates MC, Benson CB, Doubilet PM, DiSalvo DN, Brown DL, Laing FC, Rein MS, Osathanondh R. Cervical ectopic pregnancy: Results of conservative treatment. Radiology. 1994. 191:773–775.
Article
4. Kligman I, Adachi TJ, Katz E, McClamrock HD, Jockle GA, Barakat B. Conserving fertility with early management of cervical pregnancy. A case report. J Reprod Med. 1995. 40:743–746.
5. Nolan TE, Chandler PE, Hess LW, Morrison JC. Cervical pregnancy managed without hysterectomy. A case report. J Reprod Med. 1989. 34:241–243.
6. Bachus KE, Stone D, Suh B, Thickman D. Conservative management of cervical pregnancy with subsequent fertility. Am J Obstet Gynecol. 1990. 162:450–451.
Article
7. Mashiach S, Admon D, Oelsner G, Paz B, Achiron R, Zalel Y. Cervical Shirodkar cerclage may be the treatment modality of choice for cervical pregnancy. Hum Reprod. 2002. 17:493–496.
Article
8. Ryu KY, Kim SR, Cho SH, Song SY. Preoperative uterine artery embolization and evacuation in the management of cervical pregnancy. Report of two cases. J Korean Med Sci. 2001. 16:801–804.
Article
9. Lobel SM, Meyerovitz MF, Benson CC, Goff B, Bengtson JM. Preoperative angiographic uterine artery embolization in the management of cervical pregnancy. Obstet Gynecol. 1990. 76:938–941.
Article
10. Spitzer D, Steiner H, Graf A, Zajc M, Staudach A. Conservative treatment of cervical pregnancy by curettage and local prostaglandin injection. Hum Reprod. 1997. 12:860–866.
Article
11. Hardy TJ. Hysteroscopic resection of a cervical ectopic pregnancy. J Am Assoc Gynecol Laparosc. 2002. 9:370–371.
Article
12. Ash S, Farrell SA. Hysteroscopic resection of a cervical ectopic pregnancy. Fertil Steril. 1996. 66:842–844.
Article
13. Lin H, Kung FT. Combination of laparoscopic bilateral uterine artery ligation and intraamniotic methotrexate injection for conservative management of cervical pregnancy. J Am Assoc Gynecol Laparosc. 2003. 10:215–218.
Article
14. Nelson RM. Bilateral internal iliac artery ligation in cervical pregnancy: conservation of reproductive function. Am J Obstet Gynecol. 1979. 134:145–150.
Article
15. Dotters DJ, Katz VL, Kuller JA, McCoy MC. Successful treatment of a cervical pregnancy with a single low dose methotrexate regimen. Eur J Obstet Gynecol Reprod Biol. 1995. 60:187–189.
Article
16. Kaplan BR, Brandt T, Javaheri G, Scommegna A. Nonsurgical treatment of a viable cervical pregnancy with intra-amniotic methotrexate. Fertil Steril. 1990. 53:941–943.
Article
17. Timor-Tritsch IE, Monteagudo A, Mandeville EO, Peisner DB, Anaya GP, Pirrone EC. Successful management of viable cervical pregnancy by local injection of methotrexate guided by transvaginal ultrasonography. Am J Obstet Gynecol. 1994. 170:737–739.
Article
18. Brand E, Gibbs RS, Davidson SA. Advanced cervical pregnancy treated with actinomycin-D. Br J Obstet Gynaecol. 1993. 100:491–492.
Article
19. Segna RA, Mitchell DR, Misas JE. Successful treatment of cervical pregnancy with oral etoposide. Obstet Gynecol. 1990. 76:945–947.
Article
20. Wolcott HD, Kaunitz AM, Nuss RC, Benrubi GE. Successful pregnancy after previous conservative treatment of an advanced cervical pregnancy. Obstet Gynecol. 1988. 71:1023–1025.
21. Hofmann HM, Urdl W, Hofler H, Honigl W, Tamussino K. Cervical pregnancy: case reports and current concepts in diagnosis and treatment. Arch Gynecol Obstet. 1987. 241:63–69.
Article
22. Hellmen LM, Kobayashi M, Fillisti L, Lavenhar M, Cromb E. Growth and development of the human fetus prior to the twentieth weeks of gestation. Am J Obstet Gynecol. 1969. 103:789–800.
23. Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol. 1993. 168:1759–1765.
Article
24. Henry MA, Gentry WL. Single injection of methotrexate for treatment of ectopic pregnancies. Am J Obstet Gynecol. 1994. 171:1584–1587.
Article
25. Ginsburg ES, Frates MC, Rein MS, Fox JH, Hornstein MD, Friedman AJ. Early diagnosis and treatment of cervical pregnancy in vitro fertilization program. Fertil Steril. 1994. 61:966–969.
26. Poindexter AN 3rd, Thompson DJ, Gibbons WE, Findley WE, Dodson MG, Young RL. Residual embryos in failed embryo transfer. Fertil Steril. 1986. 46:262–267.
27. Ushakov FB, Elchalal U, Aceman PJ, Schenker JG. Cervical pregnancy: past and future. Obstet Gynecol Surv. 1996. 52:45–59.
28. Kung FT, Chang SY. Efficacy of methotrexate treatment in viable and nonviable cervical pregnancies. Am J Obstet Gynecol. 1999. 181:1438–1444.
Article
29. Kung FT, Chang SY, Tsai YC, Hwang FR, Hsu TY, Soong YK. Subsequent reproduction and obstetric outcome after methotrexate treatment of cervical pregnancy: a review of original literature and international collaborative follow-up. Hum Reprod. 1997. 12:591–595.
Article
30. Yoshida S, Furuhashi M, Itakura A, Furuhashi Y, Suganuma N. Conservative handling of the uterus on a 10-week cervical pregnancy case. Nagoya J Med Sci. 1997. 60:139–143.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr